Decentralized Clinical Trials Are Changing Drug Development: Market to Reach USD 15.61 Billion by 2034
Clinical trials are the backbone of medical progress, but traditional trials can be slow, costly and difficult for patients to join. Participants often need to travel long distances to research sites, take time off work and attend frequent in-person visits. These barriers contribute to recruitment delays, high dropout rates and trial populations that do not reflect the diversity of real-world...
0 Commentarios 0 Acciones 7 Views 0 Vista previa
AC Mingle https://acmingle.com